Background and Aims: breast reconstruction with silicone prosthesis following nipplesparing mastectomy has become widely accepted as a reconstruction option in women requiring mastectomy for cancer. the purpose of this study was to evaluate the incidence and some factors influencing early local complications in patients undergoing nsm with immediate implant reconstruction.Material and Methods: prospective study was performed on a consecutive series of 214 breast reconstructions in 205 patients. all complications during the six weeks after surgery were recorded. 42 prostheses were implanted after neoadjuvant chemotherapy, 27 patients previously had radiotherapy due to breast conserving surgery and in all other cases surgery was the primary treatment for cancer.Results: the overall six-week complication rate was 16% (35) and included: major skin flap necrosis (4%, 9 procedures), minor skin necrosis (3%, 7), major infection (2%, 5), minor infection (3%, 7), prolonged seroma formation (3%, 6), haematoma (1%, 2) and epidermolysis (1%, 2). in 6% (12) reconstruction procedures explantation of prosthesis was done. neoadjuvant chemotherapy and radiotherapy were not associated with higher rate of complications.Conclusion: nipple-sparing mastectomy with immediate implant reconstruction has acceptable morbidity rate in the hand of experienced oncoplastic surgeon and therefore should be considered as treatment option to women requiring mastectomy.
Treatment of rectal cancer, which includes periodic evaluations, may lead to earlier identification of recurrent local infiltration. Differentiation between local recurrence and other post radiation changes is frequently rather difficult. Pelvic MR examination was performed in 30 patients (20 men, 10 women) at the Institute of oncology, Sremska Kamenica. All patients underwent surgical resection of rectal cancer at the same institution. Preoperative or postoperative radiation therapy was administrated in 29 patients (93%). Criteria for detection of local recurrent tumours were based on morphologic changes, such as the presence of tumour inflltration, size increase of the mass and the change of the mass shape. Recurrent tumor inflitration was detected in 50% patients. Tumours of low differentiation histological type was predominantly found within 10 months after surgery, while moderately differentiated and high differentiated types were detected within 20 months and after 20 months after resection, respectively. Pelvic MR examination represents important diagnostic modality for recurrent rectal cancer identification.
Endorectal ultrasonography is a valuable diagnostic modality for rectal cancer staging. It is fast, safe, accurate, well tolerated by the patient and cheap procedure and therefore should be used as a diagnostic modality of the first choice in rectal cancer staging although one must take into consideration possible limitations in cases of preoperative chemoradiation.
Discovery of radioactive X-rays in 1895 by Wilhelm Conrad Roentgen marked the beginning of significant events in diagnostics and treatment of many diseases. The idea of using X-rays in treatment of malignant diseases was born the same year, when X rays were used for treatment of local relapse of breast cancer, upon initiative of medical student Emil Grubbe. This event was followed by important discoveries of radioactive elements. Marie and Pierre Curie discovered polonium and radium and were awarded the Nobel Prize for their discovery in 1903 and 1911. Their daughter, Irène Curie, joined their research on radioactivity and was awarded the Nobel Prize in 1935. The potentials of radiotherapy became increasingly exploited in treatment of oncological patients. The beginning of radiotherapy in Novi Sad dates from 1934 with the arrival of Dr. Nikola Vujić, a specialist in internal medicine and radiology, and when the first universal X-ray generator was installed and used for therapy. After the World War II, radiotherapy was modernized by purchasing modern devices: 4-valve multi-voltage device (Siemens) for deep radiotherapy and contact radiotherapy by Chaoul. Today, radiotherapy for oncological patients in Novi Sad complies with modern trends and protocols (conformal technique). It has the most advanced technical capacities used worldwide and it takes into account the therapeutical effects and patients' quality of life
Background: Our aim was to present the effect of the neoadjuvant chemoradiation therapy on the development of the complete histopathological tumour regression in patients with locally advanced rectal cancer and its influence on a five-year survival of these patients. Methods: In total, 223 patients were included in the analysis; 109 patients had the locally advanced rectal cancer; 75 patients received the neoadjuvant chemoradiation therapy, which was later followed by surgery; 34 patients were treated with the surgery alone. The surgical procedure was done 6 to 8 weeks after the chemoradiation therapy and it was preceded by haematology and biochemical analyses. In addition, patients were examined by ultrasound and MRI imaging of liver to evaluate the effects of neoadjuvant chemoradiation therapy. Accordingly, we had two patient groups: patients with the complete histopathological tumour regression and patients with the incomplete or no regression. We performed the statistical analysis of all locally advanced rectal cancer patients and determined their survival. Results: The complete histopathological tumour regression was found in 10.7% of 75 patients who were treated with preoperative chemoradiation. The down staging of the tumour appeared in 53.3% of patients. There were no stage changes in 21.3% of patients. The disease progressed into a more severe stage in 9.3% of patients, while the effects of the preoperative chemoradiation therapy could not be determined in 5.3% of patients. The survival of patients with the complete histopathological tumour regression was 70% in a five-year period, while it was 40% in patients with incomplete histopathological regression. Conclusion: The preoperative chemoradiation therapy leads to complete histopathological tumour regression and increases a five-year survival (70%). It also leads to the increase of the number of patients who undergo radical surgery
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.